MD Anderson Cancer Center and Pfizer Oncology announce clinical collaboration
The University of Texas MD Anderson Cancer Center and Pfizer Inc. today announced that they have entered into a clinical collaboration to study novel combinations of three Pfizer investigational immuno-oncology therapies and other Pfizer agents in the treatment of various solid tumors and hematologic malignancies.
“This alliance aims to define patients with solid tumors who may benefit from immunotherapy and to develop...
Study shows diet and exercise improve treatment outcomes for obese pediatric cancer patients
Diet and exercise may improve treatment outcomes in pediatric cancer patients, according to a study at The University of Texas MD Anderson...
Tibetan yoga practice may improve sleep quality for breast cancer patients receiving chemotherapy
Participating in twice-weekly practice of Tibetan yoga may reduce sleep disturbances and improve sleep quality in breast cancer patients receiving...
Following Hurricane Harvey, MD Anderson maintains exceptional patient care, supports staff
Through dedicated teamwork, strategic planning and the support of its internal and external communities, The University of Texas MD Anderson Cancer Center has returned to full operations and continues to provide excellent care for thousands of cancer patients, including new patients. MD Anderson also is committed assisting and supporting staff affected by Hurricane Harvey. It is estimated that at least 35 percent of MD Anderson’s 20,000...
Making Cancer History®: Free seminar returns to Atlanta
The University of Texas MD Anderson Cancer Center brings its signature Making Cancer History® Seminar to Atlanta for the third time, 8:30-...